THC
Income statement / Annual
Last year (2024), Tenet Healthcare Corporation's total revenue was $20.67 B,
an increase of 0.57% from the previous year.
In 2024, Tenet Healthcare Corporation's net income was $3.20 B.
See Tenet Healthcare Corporation,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$20.67 B |
$20.55 B |
$19.17 B |
$19.49 B |
$17.64 B |
$18.48 B |
$18.31 B |
$19.18 B |
$19.62 B |
$18.63 B |
| Cost of Revenue |
$12.46 B
|
$12.74 B
|
$12.13 B
|
$12.22 B
|
$11.41 B
|
$11.77 B
|
$11.65 B
|
$12.39 B
|
$12.48 B
|
$11.95 B
|
| Gross Profit |
$8.21 B
|
$7.81 B
|
$7.05 B
|
$7.27 B
|
$6.23 B
|
$6.71 B
|
$6.66 B
|
$6.79 B
|
$7.14 B
|
$6.68 B
|
| Gross Profit Ratio |
0.4
|
0.38
|
0.37
|
0.37
|
0.35
|
0.36
|
0.36
|
0.35
|
0.36
|
0.36
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$8.80 B
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$8.80 B
|
$418.00 M
|
$412.00 M
|
$412.00 M
|
$403.00 M
|
$344.00 M
|
$0.00
|
$0.00
|
$315.00 M
|
$248.00 M
|
| Other Expenses |
-$6.55 B
|
$4.88 B
|
$4.30 B
|
$3.99 B
|
$3.84 B
|
$4.83 B
|
$5.02 B
|
$5.68 B
|
$5.58 B
|
$5.36 B
|
| Operating Expenses |
$2.25 B
|
$5.30 B
|
$4.72 B
|
$4.40 B
|
$4.24 B
|
$5.18 B
|
$5.02 B
|
$5.68 B
|
$5.89 B
|
$5.60 B
|
| Cost And Expenses |
$14.71 B
|
$18.04 B
|
$16.84 B
|
$16.61 B
|
$15.65 B
|
$16.94 B
|
$16.68 B
|
$18.07 B
|
$18.37 B
|
$17.56 B
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$826.00 M
|
$901.00 M
|
$890.00 M
|
$923.00 M
|
$1.00 B
|
$985.00 M
|
$1.00 B
|
$1.03 B
|
$979.00 M
|
$912.00 M
|
| Depreciation & Amortization |
$818.00 M
|
$870.00 M
|
$841.00 M
|
$855.00 M
|
$857.00 M
|
$850.00 M
|
$802.00 M
|
$870.00 M
|
$850.00 M
|
$797.00 M
|
| EBITDA |
$6.89 B |
$3.39 B |
$3.08 B |
$3.67 B |
$2.53 B |
$2.16 B |
$2.44 B |
$1.80 B |
$2.08 B |
$1.85 B |
| EBITDA Ratio |
0.33
|
0.16
|
0.16
|
0.19
|
0.14
|
0.12
|
0.13
|
0.09
|
0.11
|
0.1
|
| Operating Income Ratio |
0.29
|
0.12
|
0.12
|
0.15
|
0.11
|
0.08
|
0.09
|
0.06
|
0.06
|
0.06
|
| Total Other Income/Expenses Net |
-$708.00 M
|
-$893.00 M
|
-$988.00 M
|
-$983.00 M
|
-$1.32 B
|
-$1.22 B
|
-$1.01 B
|
-$1.21 B
|
-$999.00 M
|
-$933.00 M
|
| Income Before Tax |
$5.25 B
|
$1.62 B
|
$1.35 B
|
$1.89 B
|
$671.00 M
|
$320.00 M
|
$629.00 M
|
-$101.00 M
|
$248.00 M
|
$144.00 M
|
| Income Before Tax Ratio |
0.25
|
0.08
|
0.07
|
0.1
|
0.04
|
0.02
|
0.03
|
-0.01
|
0.01
|
0.01
|
| Income Tax Expense |
$1.18 B
|
$306.00 M
|
$344.00 M
|
$411.00 M
|
-$97.00 M
|
$160.00 M
|
$173.00 M
|
$219.00 M
|
$67.00 M
|
$68.00 M
|
| Net Income |
$3.20 B
|
$611.00 M
|
$411.00 M
|
$914.00 M
|
$399.00 M
|
-$215.00 M
|
$104.00 M
|
-$704.00 M
|
-$192.00 M
|
-$140.00 M
|
| Net Income Ratio |
0.15
|
0.03
|
0.02
|
0.05
|
0.02
|
-0.01
|
0.01
|
-0.04
|
-0.01
|
-0.01
|
| EPS |
33.02 |
6.01 |
3.84 |
8.55 |
3.8 |
-2.24 |
1.09 |
-7 |
-1.93 |
-1.41 |
| EPS Diluted |
32.7 |
5.71 |
3.79 |
8.42 |
3.75 |
-2.24 |
1.07 |
-7 |
-1.93 |
-1.41 |
| Weighted Average Shares Out |
$96.90 M
|
$101.64 M
|
$106.93 M
|
$106.83 M
|
$105.01 M
|
$103.40 M
|
$102.11 M
|
$100.57 M
|
$99.32 M
|
$99.17 M
|
| Weighted Average Shares Out Diluted |
$97.88 M
|
$104.80 M
|
$110.52 M
|
$108.57 M
|
$106.26 M
|
$103.40 M
|
$103.88 M
|
$100.59 M
|
$99.32 M
|
$99.17 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
